More Cardiovascular Disease Found in Lean People with Non-Alcoholic Fatty Liver Disease Than in Those Who are Overweight with the Same Condition
New study surprises researchers who say doctors may overlook lean patients with nonalcoholic fatty liver disease
Alarming Rise Found in Esophageal Cancer and Barrett’s Esophagus in Middle-Aged Adults
Researchers say findings suggest urgent need for earlier endoscopic screening
Gallstone Disease Shown to be Strong Predictor of Pancreatic Cancer
Study finds cancer incidence nearly six times higher within one year of gallbladder diagnosis
Antibiotic Use Associated with Inflammatory Bowel Disease in Older Adults
Crohn’s disease and ulcerative colitis higher in seniors with more rounds of antibiotic treatment
IBS Patients’ Symptoms Improved Under COVID-19 Lockdown Orders
Smart Toilet May Soon Analyze Stool for Health Problems
COVID-19 Pandemic Sees Increased Consults for Alcohol-Related GI and Liver Diseases
Proportion of consults remained elevated even after re-opening Bethesda, MD (May 14, 2021) — Inpatient consults for alcohol-related gastrointestinal (GI) and liver diseases have surged since the beginning of the COVID-19 pandemic and remained elevated, according to research selected for presentation at Digestive Disease Week® (DDW) 2021. The proportion of patients that required inpatient endoscopic […]
Pancreatic Cancer Trials Fail to Include Minorities Despite Worse Outcomes
More trials report race, ethnicity and gender, but disparities in trial inclusion continue Bethesda, MD (May 14, 2021) — Despite the fact that certain racial and ethnic minorities get pancreatic cancer more often, are diagnosed at a younger age and die sooner, clinical trials fail to include representative proportions of non-White patients at every phase […]
Pairing Bariatric Procedure with Diabetes Drug Increases Weight Loss
Endoscopic sleeve gastroplasty combined with semaglutide produces results similar to surgery Bethesda, MD (May 14, 2021) — Combining minimally invasive endoscopic sleeve gastroplasty (ESG) with the diabetes drug semaglutide can provide additional significant weight loss for patients who are not candidates for invasive weight-loss surgery, according to research that was selected for presentation at Digestive […]
Dawn-to-sunset fasting suggests potential new treatment for obesity-related conditions
San Diego, CA (May 21, 2019) — Fasting from dawn to sunset for 30 days increased levels of proteins that play a crucial role in improving insulin resistance and protecting against the risks from a high-fat, high-sugar diet, according to research presented at Digestive Disease Week® (DDW) 2019. The study, which was based on the […]